Year: 2019

Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer

Phase 2 BRACELET-1 study to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab...

Catholic Senior Housing and Health Care Services, Inc. (CSHHCS) and Somatix Inc., Launch a Program to Trial SafeBeing™ A novel gesture detection RPM Solution for Seniors

error: Content is protected !!